维普期刊资源整合服务平台（V6.5）

127篇 您的检索式：作者名="Dubernet"

选中清除导出查看参考文献查看引证文献引用追踪共7页首页上一页第1页下一页末页 /7 跳转

	题名	作者	年代	出处	被引量
1	Reversion of Multidrug Resistance with Polyalkylcyanoacrylate Nanoparticles:Towards a Mechanism of Action显示文摘	AC de Verdiere Dubernet C Nemati F	1997	Br J Cancer1997，76，1：	1
2	Nanoparticles in cancer therapy and diagnosis显示文摘	BRIGGER I DUBERNET C COUVREUR P	2002	Adv Drug Deliv Rev2002，54，5：	1
3	Cationicvectors in ocular drug delivery显示文摘	Couvreur P Lambert G Dubernet C	2004	J Drug Target2004，12，910：	1
4	A PCR-based method for identification of lactobacilli at the genus level显示文摘	Dubernet S Desmasures N Gu6guen M	2002	FEMS Microbiology Letters2002，214，2：	1
5	Reversionof multidrug resistance by co-encapsulation of doxorubicinand cyclosporin A in polyalkylcyanoacrylate nanoparticles显示文摘	SOMA C E DUBERNET C BENTOLILA D	2000	Biomaterials2000，21，1：	1
6	Investigation of the role of macrophages on the cytotoxicity of doxorubicin and doxorubicin-loaded nanoparticles on M5076 cells in vitro 显示文摘	Soma CE Dubernet C Barratt G	2000	Journal of Controlled Release2000，68，2：	1
7	Drug delivery to resistant tumors:the potential of poly(alkylcyanoacrylate) nanoparticles显示文摘	C Vauthier C Dubernet C Chauvierre	2003	J Controlled Release2003，93，：	1
8	Ability of doxorubicin-loaded nanoparticles to overcome multidrug resistance of tumor cells after their capture by macrophages 显示文摘	Soma CE Dubernet C Barratt G	1999	Pharm Res1999，16，11：	1
9	Polyalkycyanoacrylate as biodegradable materials for biomedical applications显示文摘	Christine Vauthier Catherine Dubernet Elias Fattal	2003	Advanced Delivery Reviews2003，55，：	1
10	Uptake of doxoru bicin from loaded nanoparticles in multidrug - resistant leukemic murine cells显示文摘	Colin de Verdiere A Dubernet C Nemati F	1994	Cancer Chemother Pharmacol1994，33，6：	1
11	显示文摘	Verdibre A C Dubernet C Nematil E	1994	Cancer Chemother Pharmacol1994，33，：	1
12	Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanopartides显示文摘	Claire Emilienne Soma Catherine Dubernet Dvora Bentolila	2000	Biomaterials2000，21，：	1
13	Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclasporin A in polyalkylcyanoacrylate nanoparticles显示文摘	Soma CE Dubernet C Bentolila D	2000	Biomaterials2000，21，1：	1
14	Cationic emulsions improves the delivery of oligonucleotides to leukemic P388/ADR cells in ascite 显示文摘	Teixeira H Dubernet C Chacun H	2003	J Control Re- ~ease2003，89，3：	1
15	Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanoparticles 显示文摘	Soma CE Dubernet C Bentolila D	2000	Biomaterials2000，21，1：	1
16	Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications显示文摘	Vauthier C Dubernet C Fattal E	2003	Adv Drug DelivRev2003，55，4：	1
17	Nanoparticles in cancer therapy and diagnosis显示文摘	Dubernet C Couvreur P	2002	Adv Drug Deliver Rev2002，54，5：	1
18	Nanoparticles in cancer therapy and diagnosis显示文摘	Brigger I Dubernet C Couvreur P	2002	Ad Drug Delivery Reviews2002，54，5：	1
19	Nanoparticles in cancer therapy and diagnosis显示文摘	Brigger I Dubernet C Couveur P	2002	Adv Drug Deliv Rev2002，54，5：	1
20	Investigation of the role of macrophages on cytotoxicity of doxorubicin and doxorubicin-loaded nanoparticles on M5076 cells in vitro显示文摘	Soma CE Dubernet C Barratt G	2000	J Control Release2000，68，2：	1

返回顶部每页显示：

共7页首页上一页第1页下一页末页 /7 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示